A growing controversy in England’s healthcare system is raising serious concerns about the safety of children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Recent reporting by The Guardian reveals that poorly regulated private clinics may be putting young patients at risk, sparking urgent calls for reform.
At the center of the issue is a troubling trend: clinics diagnosing and medicating children with ADHD without proper medical assessments. While demand for ADHD services continues to surge, experts warn that speed and convenience may be coming at the cost of safety.
A System Under Pressure
ADHD diagnoses have increased sharply in recent years, driven by greater awareness, reduced stigma, and long waiting lists in public healthcare. In England, the National Health Service (NHS) is struggling to keep up, with hundreds of thousands of people waiting for assessments.
As a result, many families are turning to private clinics for faster diagnoses and treatment. These clinics often operate under the NHS “Right to Choose” scheme, allowing patients to seek care outside the public system. While this pathway improves access, it has also created a rapidly expanding private market with uneven oversight.
Experts say this surge has exposed a major weakness: a lack of consistent regulation across providers.
The Rise of “Remote-Only” Diagnosis
One of the most alarming findings is the growing reliance on remote-only assessments. In many cases, children are diagnosed via video consultations, sometimes without ever meeting a clinician in person.
Doctors warn that this approach can lead to incomplete evaluations. ADHD is a complex neurodevelopmental condition that requires careful assessment, including behavioral history, environmental factors, and physical health checks. However, some clinics are reportedly relying on short online consultations and basic questionnaires.
Even more concerning, parents are sometimes asked to provide key medical data—such as weight or blood pressure—without professional verification.
Critics argue that this “checklist-style” diagnosis risks oversimplifying a condition that demands thorough clinical judgment.
Medication Without Proper Safeguards
The risks become even more serious when medication is involved. ADHD is commonly treated with stimulant drugs, which can significantly improve symptoms but also carry potential side effects.
According to national guidelines, children should undergo a full physical examination—including cardiovascular checks—before starting medication.
Yet doctors report cases where these safeguards were skipped entirely.
In one instance highlighted in the report, a child was prescribed ADHD medication without a proper in-person exam and was later found to have an underlying heart condition.
Such cases underscore the potential dangers of bypassing medical protocols. Stimulant medications can affect heart rate and blood pressure, making undiagnosed conditions particularly risky.
Healthcare professionals have described these practices as not just inadequate, but potentially negligent.
A Fragmented and Confusing System
Beyond individual cases, the issue reflects a broader systemic problem. The ADHD care pathway in England has become increasingly fragmented, with responsibilities split between private providers, general practitioners (GPs), and NHS services.
This fragmentation often leads to confusion over who is responsible for patient safety. For example, GPs may be asked to continue prescribing medication initiated by private clinics, even if they have concerns about the quality of the initial assessment.
Doctors say this creates a “clinical grey zone,” where accountability is unclear and risks can fall through the cracks.
In some cases, private diagnoses are even rejected by NHS providers for failing to meet national standards, forcing families to repeat the process and delaying treatment further.
The Demand Driving the Crisis
At the heart of the issue is overwhelming demand. ADHD services are under unprecedented strain, with waiting times stretching into years in some areas.
This backlog has pushed families toward private options, fueling rapid growth in the sector. Spending on private ADHD services has more than tripled in recent years, highlighting the scale of the shift.
However, this expansion has outpaced regulation. Investigations suggest that many providers operate without standardized training requirements or consistent oversight, leading to wide variation in the quality of care.
Some experts estimate that a significant proportion of private assessments may fall below acceptable standards.
Efforts to Restore Safety
In response to mounting concerns, health authorities are beginning to act. In Greater Manchester, new rules now require face-to-face assessments before ADHD medication can be prescribed.
These measures aim to ensure that children receive proper physical evaluations and that clinicians follow established guidelines.
At a national level, the NHS has launched reviews into ADHD services, focusing on improving access, consistency, and patient safety.
However, reforming the system will not be easy. Experts emphasize that addressing the crisis will require both increased capacity in public services and stronger regulation of private providers.
Balancing Access and Safety
The controversy highlights a difficult balancing act. On one hand, faster access to ADHD diagnosis and treatment can be life-changing for children and families. On the other, rushed or inadequate care can lead to serious harm.
Importantly, clinicians stress that ADHD itself is a legitimate and often debilitating condition. The issue is not overdiagnosis alone, but how diagnoses are made and managed.
As one expert noted, the real danger lies in a system that prioritizes speed over thoroughness.
A Wake-Up Call for Healthcare Systems
While the current debate is centered in England, the implications are global. Many countries face similar challenges: rising demand for mental health services, limited public resources, and growing reliance on private care.
The situation serves as a warning of what can happen when healthcare systems struggle to keep pace with need. Without proper safeguards, gaps in care can emerge—leaving vulnerable patients at risk.
Conclusion
The findings reported by The Guardian paint a concerning picture of an overstretched system where children may be exposed to unsafe practices.
At its core, the issue is not about ADHD treatment itself, but about ensuring that care is delivered responsibly. Accurate diagnosis, thorough medical evaluation, and coordinated follow-up are essential to protecting patients.
As demand continues to rise, the challenge for healthcare providers and policymakers is clear: expand access without compromising safety.
Until then, the warning from doctors remains urgent—when it comes to children’s health, shortcuts can have lasting consequences.